公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2012 | HLA-B*15:02 is associated with anemia in patients with chronic hepatitis C treated with pegylated interferon-α and ribavirin | Tseng C.-W.; Hsieh Y.-H.; CHIN-KUO CHANG ; Lai N.-S.; Hung T.-H.; Wu S.-F.; Tseng K.-C. | Tissue Antigens | 2 | 1 | |
2011 | Identification of 14-3-3β in human gastric cancer cells and its potency as a diagnostic and prognostic biomarker | Tseng C.-W.; JYH-CHIN YANG ; CHIUNG-NIEN CHEN ; Huang H.-C.; Chuang K.-N.; Lin C.-C.; HONG-SHIEE LAI ; PO-HUANG LEE ; KING-JEN CHANG ; Juan H.-F. | Proteomics | 38 | 37 | |
2011 | Integrative network analysis reveals active microRNAs and their functions in gastric cancer | Tseng C.-W.; Lin C.-C.; CHIUNG-NIEN CHEN ; Huang H.-C.; Juan H.-F. | BMC Systems Biology | 86 | 79 | |
2010 | RNAi knock-down of the Litopenaeus vannamei Toll gene (LvToll) significantly increases mortality and reduces bacterial clearance after challenge with Vibrio harveyi | Han-Ching Wang K.C.; Tseng C.-W.; HAN YOU LIN ; Chen I.-T.; Chen Y.-H.; Chen Y.-M.; Chen T.-Y.; Yang H.-L. | Developmental and Comparative Immunology | |||
2021 | Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan | CHEN-HUA LIU ; Chen P.-Y.; Chen J.-J.; Lo C.-C.; Su W.-W.; Tseng K.-C.; CHUN-JEN LIU ; Huang C.-S.; Huang K.-J.; Yang S.-S.; Peng C.-Y.; Tsai M.-C.; Kao W.-Y.; Chang C.-Y.; Shih Y.-L.; YU-JEN FANG ; Chen C.-Y.; Lee P.-L.; Huang J.-J.; Su P.-Y.; Tseng C.-W.; CHIEN-CHING HUNG ; Chang C.-H.; Huang Y.-J.; Lai H.-C.; Chang C.-C.; Lee F.-J.; Hsieh T. Y.; JIA-HORNG KAO | Hepatology International | 16 | 14 | |
2021 | Sofosbuvir/velpatasvir plus ribavirin for child-pugh b and child-pugh c hepatitis c virus-related cirrhosis | CHEN-HUA LIU ; Chen C.-Y.; Su W.-W.; CHUN-JEN LIU ; Lo C.-C.; Huang K.-J.; Chen J.-J.; Tseng K.-C.; Chang C.-Y.; Peng C.-Y.; Shih Y.-L.; Huang C.-S.; Kao W.-Y.; Yang S.-S.; Tsai M.-C.; Wu J.-H.; Chen P.-Y.; Su P.-Y.; Hwang J.-J.; YU-JEN FANG ; Lee P.-L.; Tseng C.-W.; Lee F.-J.; Lai H.-C.; Hsieh T.-Y.; Chang C.-C.; Chang C.-H.; Huang Y.-J.; JIA-HORNG KAO | Clinical and Molecular Hepatology | 8 | 8 | |
2020 | Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment | CHEN-HUA LIU ; Chen C.-Y.; Su W.-W.; Tseng K.-C.; Lo C.-C.; CHUN-JEN LIU ; Chen J.-J.; Peng C.-Y.; Shih Y.-L.; Yang S.-S.; Huang C.-S.; Huang K.-J.; Chang C.-Y.; Tsai M.-C.; Kao W.-Y.; YU-JEN FANG ; Chen P.-Y.; Su P.-Y.; Tseng C.-W.; Huang J.-J.; Lee P.-L.; Lai H.-C.; Hsieh T.-Y.; Chang C.-H.; Huang Y.-J.; Lee F.-J.; Chang C.-C.; JIA-HORNG KAO | Gut | 26 | 27 | |
2018 | Transketolase Regulates the Metabolic Switch to Control Breast Cancer Cell Metastasis via the a-Ketoglutarate Signaling Pathway | Tseng C.-W.; WEN-HUNG KUO ; Chan S.-H.; Chan H.-L.; KING-JEN CHANG ; Wang L.-H. | Cancer Research | 82 | 73 | |
2018 | Upregulation of LGALS1 is associated with oral cancer metastasis | Li J.-M.; Tseng C.-W.; Lin C.-C.; Law C.-H.; Chien Y.-A.; WEN-HUNG KUO ; Chou H.-C.; Wang W.-C.; Chan H.-L. | Therapeutic Advances in Medical Oncology | 24 | 29 |